The immunoassay market is projected to grow from USD 34.2 billion in 2025 to USD 55.6 billion by 2035, at a CAGR of 5.0%. Reagents & Kits will dominate with a 48.0% market share, while enzyme immunoassays rapid test will lead the technology type segment with a 42.0% share.